Journal of Alzheimer's Disease
Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.

TitleResearch Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.
Publication TypeJournal Article
Year of Publication2024
AuthorsSmith, HStevens, Robinson, JO, Levchenko, A, Pereira, S, Pascual, B, Bradbury, K, Arbones, V, Fong, J, Shulman, JM, McGuire, AL, Masdeu, J
JournalJ Alzheimers Dis
Volume97
Issue3
Pagination1261-1274
Date Published2024
ISSN1875-8908
KeywordsAlzheimer Disease, Amyloid, Amyloid beta-Peptides, Cognitive Dysfunction, Emotions, Humans, Positron-Emission Tomography
Abstract

BACKGROUND: Understanding research participants' responses to learning Alzheimer's disease (AD) risk information is important to inform clinical implementation of precision diagnostics given rapid advances in disease modifying therapies.

OBJECTIVE: We assessed participants' perspectives on the meaning of their amyloid positron emission tomography (PET) imaging results for their health, self-efficacy to understand their results, psychological impact of learning their results, experience receiving their results from the clinical team, and interest in genetic testing for AD risk.

METHODS: We surveyed individuals who were being clinically evaluated for AD and received PET imaging six weeks after the return of results. We analyzed responses to close-ended survey items by PET result using Fisher's exact test and qualitatively coded open-ended responses.

RESULTS: A total of 88 participants completed surveys, most of whom had mild cognitive impairment due to AD (38.6%), AD (28.4%), or were cognitively unimpaired (21.6%). Participants subjectively understood their results (25.3% strongly agreed, 41.8% agreed), which could help them plan (16.5% strongly agreed, 49.4% agreed). Participants with a negative PET result (n = 25) reported feelings of relief (Fisher's exact p < 0.001) and happiness (p < 0.001) more frequently than those with a positive result. Most participants felt that they were treated respectfully and were comfortable voicing concerns during the disclosure process. Genetic testing was anticipated to be useful for medical care decisions (48.2%) and to inform family members about AD risk (42.9%).

CONCLUSIONS: Participants had high subjective understanding and self-efficacy around their PET results and did not experience negative psychological effects. Interest in genetic testing was high.

DOI10.3233/JAD-230609
Alternate JournalJ Alzheimers Dis
PubMed ID38250770
PubMed Central IDPMC10894569
E-mail Icon
Comment Icon
  • Comment
Bookmark Icon Bookmark Recommend Icon Recommend Follow Icon Follow
  • Comment
| Bookmark | Recommend | Follow

Source URL: https://www.j-alz.com/content/research-participants-perspectives-precision-diagnostics-alzheimers-disease